Weed Talk NEWS – Massroots Goes PPP, High Times Ends the Storm, and Joe Biden’s Black America Plan
What a wild week in cannabis as Massoots flaunts a PPP government loan, High Times gets a new CEO for the 3rd time in less than a year, and Joe Biden has a plan for Black America.
Join us as Cannabis.net and Pro Cannabis Media team up with Debra Borchardt of the Green Market Report to bring you this week’s cannabis news, insights, and commentary. You can watch the show by clicking on the YouTube video above and read the full transcript below.
Hi everyone. Welcome to another edition of Weed Talk News. I’m Jimmy young from Pro Cannabis Media.
And I’m Curt Dalton from Cannabis.Net.
And we’ve got an amazing amount of news items for you this week as always, an interesting week in the world of cannabis. In fact, you could even make a case that you’ve got politics, you’ve got weed, you’ve got racism, you’ve got guns. I mean, and you’ve got golf. Unbelievable Curt.
Lawyers, guns and money Jimmy, the matrix is broken. We’re living in Banana Land. We have Stormy Simon out at High Times. We have MassRoots playing a game of dangerous chicken with the federal government and right away we’re going to Debra Borchardt to give us the headlines for this week.
I’m Debra Borchardt and this is the Weed Talk Business recap, MassRoots based industry backlash this week after the troubled cannabis platform company announced it got a payroll protection loan of $50,000. A lot of people pointed out, if you earn income from plant-touching cannabis companies, you can’t actually get this loan. There were demands in social media that the company return the money, but so far, CEO Isaac Dietrich has said, no. Iconic cannabis publisher High Times reported that its CEO Stormy Simon resigned and was replaced by former Green Growth Brands, CEO Peter Horvath. This is the third CEO in just one year for the company.
Cannabis REIT Innovative Industrial Properties reported first quarter revenues of $21 million and net income of $11 million. The company also said it is deferring rent for some of its tenants due to the COVID crisis. And finally analytics from BDSA said that sales increased in March despite the pandemic for all the legal States except Nevada and Massachusetts. Nevada because it lost the tourist crowd and Massachusetts sales fell because the governor closed recreational dispensaries. And that’s it for this week. Have a happy mother’s day everyone. I’m Debra Borchardt from the Green Market Report, reporting for Weed Talk News.
Thanks Debra. Well, I know for one Curt, you were not surprised about Stormy Simon’s short reign at the helm of High Times.
No, not at all. Unfortunately, she’s a very nice person and seems like a good human being. We had done that interview in February that we published and she just didn’t seem like a good fit and we questioned whether she was getting set up for something like this. Why does she go walking the glass cliff as it’s referred to for a female or a minority to be appointed CEO at a very trying time in a company’s history in order for if something bad was coming, maybe the punishment or the criticism would be lessened if you have a female CEO or a minority CEO. And unfortunately Stormy’s out after only three or four months and we’ll have to see what happens with their IPO in the future
And she has not told her side of the story as far as you know yet, right?
As according to why from what I hear, she’s going to wait a month and then talk to people, but she did put out a post on her LinkedIn that was a meme that was a little bit cryptic, but as far as an interview, she has not given one yet.
And of course, what’s up with this MassRoots story? You and I talked about this earlier this week when it first broke. You know this situation and is this guy kind of playing with fire with the US government a little bit?
Yeah, he certainly is. So MassRoots is a cannabis tech platform that applied for a PPP loan, the Payroll Protection Plan and he got it, $50,000 good for him. I think the mistake happened when he did a huge press release about it that got picked up by CNBC and Yahoo! Finance and of course we questions he’s not eligible for it. If you have any income from the cannabis plant or dealing with companies that deal in cannabis, you are not eligible. Isaac then doubled down their CEO and did an interview with a cannabis law blog and their lawyers basically said, “No, you are not eligible if you have any income from a cannabis type company.” The other problem in that interview is he mentioned Bank of America, kind of giving him the okay to go for it, he mentioned his law firm, giving him the okay that you could go for it.
So now he’s implicated Bank of America in possible PPP fraud, he’s implicated his lawyers telling him it was okay and then if doubling down wasn’t bad enough, he tripled down last night and tweeted and Facebooked the president of the United States and the secretary of state saying, “I got $50,000 we should open this up to all cannabis companies.” So at some point Jimmy, it’s a really risky proposition. It’s not good for the industry and this could blow up in his face in the fact you could lose a bank account, you could have your lawyers drop you as a client and you could come under federal indictment like some people have for a PPP fraud.
And again send lawyers guns and money because this is where the, you know what has hit the fan. Here in Massachusetts of course where this show originates, the governor, Charlie Baker had extended his ban to May 18th. We’re all supposed to stay at home for non-essential workers and now of course things are softening up a little bit. Leading the way is one of my favorite sports golf. They’ve opened up some of the golf courses in the state for social distance play. I don’t know if you saw some of the details on this Curt, but do you know they’re actually taking the… you’re supposed to put the little golf ball in the hole, right? That’s the nature of the game, right?
Basically what they’re doing is they’re taking the cup and they’re bringing it to the top with the flag. So you really only have to hit the flag for the ball to go in the hole because there’s not to be a hole. It’s just going to be sitting there so the person who makes the pot has to go over, pick up his own or her own golf ball and keep playing with that. It’s a strange world now, isn’t it?
We’re going back to five-year-old birthday parties where you just have to kind of hit the little standing pin and you’re all set. The funniest part after the great interview with Keith and talking about what they’re doing in Cambridge and how Massachusetts is adjusting to this pandemic. Right now we’re at, you can go hit your 9-iron, you can go… Governor Baker also allowed, actually the Supreme court allowed gun shops to open. So you can hit your 9-iron, pull out your 45 but you’re not allowed to go buy a joint. So what are we coming to here?
Right, and you mentioned Keith Cooper, the CEO of Revolutionary Clinics, one of the larger medical dispensaries here in Massachusetts. Curt and I had a chance to sit down with him and I flat out asked him, “So are adult-use recreational stores going to open on May 19th?” Here’s what he had to say.
I don’t know that May 19th is a realistic date frankly, just a couple of weeks from now. You’ve seen that there’s already been indications of certain industries and businesses that are going to be allowed to open healthcare being at the top of the list for obvious reasons with people staying away from healthcare facilities that really need to be there, for surgeries or or procedures. I think there’s a bunch of other industries, golf industry for example, that feels like a relatively easy decision because it’s easy to stay socially distant. We’ll be in that first wave I think Jimmy of businesses that have shown that they can open and have a plan to do that responsibly and productively. I don’t know that the 19th is the right date. What we would like is a date.
So we really don’t know at the time of this taping of this newscast Curt, exactly what’s going to happen in Massachusetts as far as adult-use cannabis dispensaries go. Obviously Keith Cooper’s right in the middle of it. He of course is trying to help out his own industry and only time will tell. Maybe even next week we’ll have an answer to how the Bay State is going to ramp up their adult-use cannabis sales again. And a lot of eyes are on the State of Massachusetts because it is the only State for adult-use recreational in legal States that banned them. You know what I’m saying?
Yeah. And governor Baker mentioned that where one of his concerns was to ban the out-of-state people coming in. Now if you had legal rec in Maine, New Hampshire, Connecticut, New York, you wouldn’t have people coming into the state to buy it. So that plays right into what he said. He said, “I don’t think it’s going to be the 18th,” but certainly sounded like it would be coming after that so that’s good news.
Absolutely. And what isn’t good news came out of South Carolina overnight where a former, actually a current Kansas City Chiefs player got busted for possession of cannabis because he was smoking a joint and I believe an 1/8th of an ounce of cannabis in his car. But this is another example again of law enforcement and people of color getting hassled.
And just another example too, I’m sure Steve DeAngelo would agree to we need federal criminal cannabis reform. And people who are using it, even though the NFL has relaxed their policies and the new CBA, which I’m sure Biden was thinking or thought was okay, it has not changed federal law and that is the big problem.
And yet federal prosecutors, even state prosecutors have said they really don’t want to waste their time prosecuting small possession cannabis crimes anymore. Needless to say, with the COVID-19 crisis, there are movements as you know, to be more considered a public safety than worrying about a guy or a girl who’s got a joint on them or a small amount of cannabis and bringing them into jail and then prosecuting them and… It’s just the time has come and I think we’ve even seen it now in our political arena with the democratic candidate, presumed nominee, I guess is the way to look at Joe Biden at this point who came out with his plan for Black America and that included an expungement of these cannabis crimes where people are in jail for very small amounts of carrying weed and getting busted for it. And as you know, certainly more people of color are in jail for these kinds of crimes than any other ethnic group.
It is a small step forward, but Biden is the only democratic nominee not to want to legalize. He just wants to decriminalize and it just again shows how tone-deaf I think he is as far as his plan for Black America, almost like a token gift or here’s what I’m going to do for you is just decriminalize and clean up your records. We need someone that’s going to step in, legalize at the federal level tax it, makes sure the products are all safe, make sure people are doing it over 21 and really clean up some of the illicit market. But Biden just seems to be tone-deaf on his plan for Black America. Hey, tell you what, we’ll decriminalize it. How’s that? And I just think he’s still not getting it.
But yet that even if you look at history in our country about cannabis reform, that is the first step towards legalization. It has happened just about in every legal State now is the first step is to decriminalize it. That also will take pressure off law enforcement and it will also take pressure off prosecutors and it will certainly take pressure off a lot of the people out there who are just using it for either medicinal purposes or for recreational purposes. It’s time, I mean I’m not going to sit here and defend Joe Biden or even say, “You know what? He didn’t go as far cannabis reformers would like.” I’m just happy he’s going in the right direction and more importantly, he’s a responsible adult and that’s an improvement over what we have now. Sorry, I had to put that in there.
It’s certainly again, it’s better than nothing, but when you have candidates like Yang and Sanders who wanted full legalization and you even had more in there, I wish he would have come more to the left on that. And even Bernie said out of the conversations he had to get the endorsement from Bernie, legalizing marijuana was a non-starter for him. So it doesn’t look good. And we’ve talked about it on the show, for the next four years is Trump or Biden better just for legalizing marijuana. And I think that’s debatable. It is unfortunate.
Well, I think it’s a lesser of two evils and that’s usually how it works on a presidential election. When you get behind that curtain, a lot of people don’t like either candidates, so they take the least objective candidate and in this case, let’s just leave it at that. I think people know which side of the fence I lean on. Actually it’s so far left, it’s ridiculous. But let’s talk more about the cannabis industry on the whole here. Is this industry being held to an even a higher standard than typical industries that are opening and are highly regulated. It seems like any teeny weeny little mistake or bump in the road, they’re getting held out there like a scapegoat kind of a thing. I would think that the people and including people like Keith Cooper, they can’t make any little mistake in any type when they’re running a cannabis business. It’s a lot of pressure on this group.
It is. And because the federal law says you are a Schedule I felony drug, the anti-pot crowd is very much looking for any slip up, any stories of edibles at Halloween given out to kids and a minor getting served, any type of negative story. So it’s being held up to a lot of scrutiny. I mean, CEOs like Bruce Linton, and Joe Lusardi they’ve talked about this. We have to be perfect. We have to show the world we can do this. It’s unfair until that federal law changes. But again, little steps, at least it’s there, at least the States are decriminalizing and have medical programs at this point [inaudible 00:14:08]
The GreenWave continues to roll despite the COVID-19 crisis and the role that cannabis is playing in this pandemic is just going to be another chapter in the book as we roll towards acceptance and legalization of cannabis. And finally today we’ve got a strange but true story. Maybe it’s not so strange anymore in this world of COVID-19. I’m sure anybody, whoever, wherever you are in the United States during this pandemic, you’ve probably noticed that traffic on these highways has gone way down. I mean, Curt, you even notice that locally here in Massachusetts, right?
Definitely. It’s probably 50 to 60% less cars on highways right now. It’s the latest number I saw, if not more in some places.
And what does that say about human behavior? I think I have an opportunity here to go a little bit faster on the highway to get to where I’m going. And maybe like these three guys in California got busted because they were in a caravan of black SUVs and they had over a million, just about $950,000 of cash and I believe contraband in these cars with them. And sure enough, the California Police pulled them over and what did these guys do? They threw the money out the window onto the highway and it just boggles my mind that the people that are doing these kinds of things, they’re not the most sophisticated criminals, am I right?
You can’t teach stupid Jimmy. And honestly, if you’re going to start running a couple of million dollars in cash and cannabis and other things up and down the California Coast maybe don’t go in a caravan of a black SUVs doing 120 miles an hour but they might’ve want to go over that plan before they left the kitchen with the map on the table.
Absolutely. What they need is that guy, the professor in Money Heist if everybody’s watching that on Netflix. One of those binge shows. But anyway, needless to say, Curt, another busy week in the world of cannabis. As always a pleasure to chit-chat with you. We continue with our Weed Talk Now series and we’ve got some really good guests coming up in the next few weeks. So for now this is another edition of Weed Talk News. I’m Jimmy Young, the founder of Pro Cannabis Media.
I’m Curt Dalton from Cannabis.Net.
So that’ll do it for another edition. Remember it’s a whole new world of weed out there. Use it responsibly. Talk to you next week.
Weed Talk and in the weeds are two productions of Pro Cannabis Media supported by Revolutionary Clinics. One of the top medical cannabis dispensaries in the Massachusetts area now with three locations in Greater Boston, two in Cambridge and one on Broadway in Somerville. Rev clinics has a patient first mission. They will customize your needs as a medical patient with the proper titration and combination of strains, flavors and products. Rev clinics where the patient comes first.
SEE MORE SHOWS, READ ON…
Roger Adams and the Unexpected Discovery of CBD
The name Raphael Mechoulam has gained prominence in the last several years, as he is the man who first isolated delta-9 THC. Not as many people are familiar with the scientist Roger Adams, though he was just as important in the early research on cannabis. The story of Roger Adams and the unexpected discovery of CBD marks one of the biggest milestones in today’s cannabis research. Here’s how it happened.
Not everyone knows the name Roger Adams, or that he made the unexpected discovery of CBD. Just like not everyone knows what delta-8 THC is, or how it relates to marijuana. Both are very important. Roger Adams made some of the biggest discoveries related to identifying cannabinoids; and delta-8 THC represents what that research provided – an alternate form of THC which causes less psychoactive high, less anxiety, and less cloudy head. We support cannabis research, and all the great stuff that comes out of it. Check out our deals for delta-9 THC, delta-8 THC, and for a range of other minor cannabinoids like THCV, THCP, delta 10, HHC, THC-O and more, to experience the outcome of decades of research!
Who is this Roger Adams?
Born in 1889, Roger Adams was an organic chemist from Boston, Massachusetts. Adams is from the same family as former presidents John Adams and John Quincy Adams, and is a direct descendent of John Adam’s grandfather. Adams attended Harvard University starting in 1903, and completed his undergraduate degree in three years. He went on to earn his PhD at Radcliffe College in 1912. He was such an outstanding student that he won the Parker Traveling Scholarship for 1912-1913, and used the money to work in laboratories in and around Berlin for that time period.
In 1913, Adams returned to the US, and began working as a research assistant, teaching organic chemistry at both Harvard and Radcliffe. He left the world of Harvard in 1916, upon accepting an assistant professor position at the University of Illinois, Urbana-Champaign. He remained at this university for 56 years. Adams spent the majority of this time as the department head for chemistry, taking the role from his predecessor William A. Noyes.
While working in this position, Adams accomplished several things. Together with students he created the Adam’s Catalyst, something used in hydrogenation reactions along with an apparatus for using this catalyst. He also elucidated the composition of complex vegetable oils and plant alkaloids. In the late 1930’s he began research into the cannabis plant and isolated the cannabinoids CBN and CBD, synthesized both, found delta-9 THC, and did a partial synthesis of that as well. He also synthesized analogues of these compounds. In this way, Roger Adams was the first guy to create a synthetic cannabinoid.
Albert Hofmann: The Finding and Self-Experimentation of LSD
The psychedelic boom is just beginning, with legalizations occurring, and new bills working their way through local governments to provide more psychedelic freedom. For those still unaware, psychedelics have been proving to be a valuable medicine in the fight against mental illness. When looking back in the history of medical psychedelics to where it started, it all comes down to one man, Albert Hofmann, and his discovery of LSD.
Albert Hofmann sure started something big when he discovered LSD, but it might be a while longer before LSD is legalized. If psychedelics continue like the cannabis industry, it should happen eventually. Luckily, for now we’ve got cannabis, and all its great medicinal and recreational compounds, like delta-9 THC, delta-8 THC, and a range of other minor cannabinoids like THCV, THCP, delta 10, HHC, THC-O and more. You can go ahead and check out our weekly deals.
What are psychedelics?
Psychedelics are drugs that contain chemical compounds that cause a psychoactive reaction in a user. Such reactions include experiencing hallucinations, which means hearing, seeing, feeling, tasting, and smelling things that aren’t there. Psychedelics are also associated with creating spiritual experiences and can promote feelings of connectedness between the user and others around. Users experience euphoria, relaxation, and well-being, while also experiencing mystical sensations. Psychedelics can alter mood, perception, and cognition, though different drugs can cause different effects, and the amount taken is important.
Psychedelics are a subset of hallucinogenic drugs, which themselves are a subset of psychoactive drugs. They can be found in nature, like magic mushrooms or peyote, or made in a lab like LSD or PCP. Though psychedelics have been found generally safe in testing, getting the dose correct is important. This is the same with any type of medication, and is not specific to psychedelics. A person who takes too much oxycontin might overdose and die, a person who takes too much LSD might have a bad trip.
‘Bad trips’ are characterized by negative, or even scary, hallucinations. Users can experience feelings of dysphoria, anxiety, and panic, as well as physical symptoms like dizziness, irregular heartbeat, numbness, vomiting, and sweating and chills. Bad trips have not been known to result in death, but can certainly be a negative experience for the user, and back up that careful dosing is very important.
Many psychedelics are serotonergic, meaning they interact with serotonin receptors in the brain. This will usually cause a rush of the neurotransmitter, followed by blocking reuptake to allow for more absorption. The neurotransmitter serotonin is responsible for many functions in the human body, from mood regulation and involuntary muscle control, to transmitting signals throughout the brain.
Historical use of psychedelics
Though we treat psychedelics like we don’t know much about them in mainstream life, there is plenty of evidence they’ve been used for thousands of years, although the context they were used in, may have been different from how they’re used today. Information that we do have was obtained from ancient texts, findings, and rituals.
For example, in the Sora River Valley of Southwestern Bolivia, a pouch was found containing traces of different psychedelic compounds including both harmine and dimethyltryptamine – used to make ayahuasca; bufotenine, a psychedelic compound found in toad skin; and psilocin, a psychedelic compound of magic mushrooms. The pouch is said to be from around 900-1100 CE according to mass spectrometry carbon dating. This is the earliest finding to show the use of the plants that combine to make ayahuasca.
Other research has pointed to use of psychedelics in Mesoamerica by the Mayans, Aztecs, Olmecs, and Zapotecs. The Mayans were known for drinking balché from Lonchocarpus bark extracts, which together with honey produces a psychoactive effect (the bark can itself, but is milder without the honey). It was used for group ceremonies to get intoxicated. The cultures mentioned used the peyote plant for mescaline, hallucinogenic mushrooms, and ololiuhqui seeds, which contain lysergic acid amide, a relative to LSD.
The near-East has also been a hotspot for ancient psychedelic findings. Several artifacts have been made in that region including residues, fibers, pollen, and carbonized seeds. In fact, traces of Blue Water Lily extract, a strong narcotic, were found in Tutonkamen’s tomb which dates back to the 14th century BC. In Lebanon, 10 liters of Viper’s Bugloss was found in a storage jar in Kami del-Loz temple from the late bronze age. Viper’s Bugloss is a very strong hallucinogenic compound.
What led up to Albert Hofmann finding LSD
History is all fine and good, but in today’s world we study things in labs. In modern times, the practice of studying psychedelics began in Switzerland with a chemist named Albert Hofmann. Born in 1906, in Baden, Switzerland, Hofmann finished his chemistry degree at the University of Zurich in 1929. Immediately after graduation, he began working for the chemical company Sandoz.
When Sandoz hired Hofmann, the company had only opened a pharmaceutical department a few years before in 1917, even though the company was founded in 1886. The pharmaceutical department started with the isolation of a compound called aotamine from a fungus called ergot, which can be found in tainted rye. Ergot has been used in natural medicine traditions for many, many years, since in small doses, it has been known to quicken child birth, as well as help with the bleeding after. However, when found in tainted rye, ergot can cause incredible illness. The scientist who isolated the compound, Arthur Stoll, wanted to isolate the part that caused the constriction that allowed for the medical advantages only.
He was able to do it, isolating the compounds ergotamine and ergobasine, which enabled the ability to dose very precisely, and without other compounds from ergot getting in the way. Within the next few years, researchers at the company were able to elucidate the chemical structures of different compounds of ergot thought useful, all of which share a common nucleus. This point at which all the compounds start, is named Lysergsaure (in German), or lysergic acid. These discoveries made a lot of money for Sandoz, and helped launch a pharmaceutical department for further research and development. This is the climate that Hofmann walked into when he was hired in 1929.
Albert Hofmann and the unexpected finding of LSD
When Albert Hofmann entered the picture, the Sandoz lab was busy studying ergot, and the compounds within. Hofmann was able to establish a synthetic process to build the ergot compounds using the chemicals that make them up. He was able to synthesize active components of ergot, along with similar compounds from other plants, that were thought to be possible for medical use. Hofmann did a lot of experimentation, combining lysergic acid with other compounds to see what kind of results occurred. He did this about 24 times before something big happened.
Hofmann had been trying to find a combination that could stimulate circulation and respiration. On the 25th occasion of combining lysergic acid with another compound, Hofmann used diethylamine, a derivative of ammonia. The compound it created, was called LSD-25 at the time, or lysergic acid diethylamide. Though it did not meet the needs specifically of what he was looking for, it was noted that the created compound caused excitability in animals during testing. At the time, LSD-25 was put on the backburner, but Hofmann couldn’t forget about it, saying it was “a peculiar presentiment—the feeling that this substance could possess properties other than those established in the first investigations.”
Five years later, he felt the urge to recreate this compound again, and this time, something very strange happened. He started feeling strange. It was a Friday, so he left the lab early and returned home. When he came back into the lab the following week, he wrote this to Stoll, who was his boss at the time:
“I was forced to interrupt my work in the laboratory in the middle of the afternoon and proceed home, being affected by a remarkable restlessness, combined with a slight dizziness. At home I lay down and sank into a not unpleasant intoxicated-like condition, characterized by an extremely stimulated imagination. In a dream-like state, with eyes closed (I found the daylight to be unpleasantly glaring), I perceived an uninterrupted steam of fantastic pictures, extraordinary shapes with intense, kaleidoscopic play of colors.”
What did he do next?
When Albert Hofmann first discovered the effects of LSD, he didn’t know what caused them. First, he thought he had been exposed to some kind of chloroform solvent, but when he intentionally breathed in fumes, he didn’t get the same response. It finally occurred to him that he might have actually ingested some of the LSD-25 he was working with, despite the fact that the only place he had made contact, was his fingertips. As it was understood ergot compounds could be toxic, a lot of measures were taken for safety. Upon realizing it might have been the LSD-25, Albert Hofmann did what any good scientist would do, he began experimenting on himself.
On April 19th, 1943, Hofmann dissolved 250 millionths of a gram of lysergic acid diethylamide tartrate (the crystalized version of LSD-25), and drank it down. He did this without giving a heads up to anyone at Sandoz except his lab assistant, and he didn’t expect anything to happen. He had taken such a small dose – with the intention of slowly increasing to find the right amount, that he hadn’t expected the response that he got. After about 40 minutes, he wrote this:
“Beginning dizziness, feeling of anxiety, visual distortions, symptoms of paralysis, desire to laugh.” Due to his condition, he had to have his lab assistant take him home, which due to wartime restrictions, meant riding on bikes. One can only imagine how funny that bike ride must have been! He later said this about the experience:
“Everything in my field of vision wavered and was distorted as if seen in a curved mirror. I also had the sensation of being unable to move from the spot. Nevertheless, my assistant later told me that we had traveled very rapidly. Finally, we arrived at home safe and sound, and I was just barely capable of asking my companion to summon our family doctor and request milk from the neighbors.”
Though the symptoms were frightening, as they were unexpected, a doctor’s visit confirmed that nothing was actually wrong with Hofmann. When he had calmed down, and could speak clearly about his experience, he said this: “Everything glistened and sparkled in a fresh light. The world was as if newly created. All my senses vibrated in a condition of highest sensitivity, which persisted for the entire day.”
Hofmann continued experimentation with himself and a couple close friends. He found the setting to be a very important factor in how the trip played out. Hofmann went on to introduce this new compound to psychiatrists in the mid-1900’s like Humphry Osmond and Ronald Sandison. Osmond conducted the Saskatchewan trials in Canada. In the studies, alcoholics were given LSD to quit drinking, and according to the studies, an entire 40-45% were able to do so for at least a year after only one dose. Sandison operated out of the UK, doing his own experimentation with acid. One of his experiments included using 36 psychoneurotic patients, all of whom were cured or showed improvement after using LSD, save for two. Both doctor’s developed their own strategies for the emerging psychedelic-assisted therapy, all based on Hofmann’s experiences.
The story of acid is obviously much longer than this, but this is how it started, with Albert Hofmann and his self-experimentation of LSD. Though LSD is currently Schedule I in the US, both psilocybin and MDMA have been designated by the FDA as breakthrough therapies, and Oregon has already legalized psilocybin for medical purposes. On top of that, esketamine, a close relative of ketamine, is already approved for depression and suicidal thoughts, and is in use in clinics all over America.
LSD is a synthetic psychedelic compound, though it has roots in the ergot plant. While it was the most commonly used medical psychedelic in the mid-1900’s, it was illegalized and demonized shortly after, only now gaining attention once again for its medical benefits. With the impending legalization of other psychedelics, one can only imagine that LSD will be coming soon too.
Welcome to CBDtesters.co, your premiere location for the most current and thought provoking cannabis and psychedelics-related news worldwide. Check out the site daily to stay abreast of the quickly-moving world of legal drugs and industrial hemp, and don’t forget to sign up for our newsletter, so you always know what’s going on.
Disclaimer: Hi, I’m a researcher and writer. I’m not a doctor, lawyer, or businessperson. All information in my articles is sourced and referenced, and all opinions stated are mine. I am not giving anyone advise, and though I am more than happy to discuss topics, should someone have a further question or concern, they should seek guidance from a relevant professional.
PlatoAi. Web3 Reimagined. Data Intelligence Amplified.
Click here to access.
The Economic Impact of Cannabis | Cannabiz Media
Be the first to know when new content like this is available!
Subscribe to our newsletter to get alerts about new posts, local news, and industry insights.
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
Research and economic data collected in recent years shows that the cannabis industry positively affects the economies in states and municipalities by creating more jobs, increasing real estate values, and generating tax revenue that is used for a wide variety of purposes.
Employment Benefits from the Cannabis Industry
With the opening of cultivation facilities, manufacturing facilities, dispensaries, and retail stores to support the legal cannabis industry, jobs are created. In addition to jobs that are directly involved with the marijuana supply chain, there are hundreds of ancillary jobs needed to keep the industry going. These include accountants, lawyers, and many more.
It is estimated that the legal cannabis industry employed 321,000 full-time workers across the 37 states in the United States with operational medical and/or cannabis programs as of January 2021. Of those full-time jobs, 24% (77,000) were added during 2020 showing a significant growth trend as more states launch and expand cannabis programs.
When you add in the estimated eight to 10 ancillary businesses that are thought to support every one licensed cannabis company, the employment numbers skyrocket. Based on this data and future predictions, it’s clear that regulated cannabis markets benefit states’ economies by creating thousands or tens of thousands of new jobs.
Real Estate Benefits from the Cannabis Industry
States that have legalized medical and/or recreational cannabis are seeing a significant increase in property values and lease rates where licensed cultivators, manufacturers, dispensaries, and retailers can operate.
Due to strict zoning laws in many areas, marijuana businesses have a limited supply of properties to choose from to build their facilities. Property owners understand this and face their own risks when they rent to cannabis-related businesses. As a result, lease rates and property values skyrocket.
It’s not just commercial property and land values that benefit from the marijuana industry. A study of Colorado municipalities published in January 2018 found that housing values increased by 6% with cannabis legalization.
Tax Benefits from the Cannabis Industry
One of the easiest ways to track the economic benefit of the legal cannabis industry to states and local municipalities is through tax revenue, particularly in states that have legalized both recreational and medical cannabis since adult-use taxes are typically much higher than medical taxes. In fact, some states don’t tax medical cannabis at all, but it’s not unusual for adult-use cannabis to be taxed multiple times (excise tax, state sales tax, and local tax) and at rates as high as 15%, 17%, or even 37%.
How much do all of these taxes bring in for states? According to Motley Fool, California brought in $1,031,879,926 in tax revenue in 2020 – the most of any state. In Washington State, tax revenue in 2020 reached $469,200,000, and in Colorado, 2020 tax revenue was $387,480,110.
Taxes collected by states and local municipalities are used for a variety of purposes – from funding community programs, education, and law enforcement to paying for the costs to run the state or town’s cannabis program.
The Cannabis Industry Provides a Positive Economic Impact
When a state allows the sale of medical and/or recreational cannabis, its economy benefits. That’s the conclusion numerous researchers have made after analyzing a number of economic factors over the past several years. Specifically, employment rates, real estate values, and tax revenue all increase with the approval of medical and adult-use cannabis.
MJBizDaily reported economic data in its 2021 Annual Cannabis Business Factbook that puts the economic impact of a legal cannabis market into perspective. Consider these facts:
- Total U.S. economic impact from cannabis sales in 2021 is expected to reach $92 billion (up more than 30% from 2020).
- Total U.S. economic impact from cannabis sales will increase to upwards of $160 billion in 2025.
- For every $1 consumers and patients spend at retail locations, an additional $2.50 will be injected into the economy – much of it at the local level.
- California’s legal cannabis industry is expected to add nearly to $20 billion to the state’s economy in 2021.
- Legal cannabis markets in Colorado, Illinois, Oregon, and Washington will each add more than $10 billion to their local economies in the coming years.
- Nevada’s economic impact per person from the legal cannabis industry will be approximately $1,917 in 2021.
- Legal cannabis markets in Alaska, Colorado, and Oregon will each deliver approximately $1,500 per person into their economies this year.
- California will deliver an estimated economic impact per person of $500 in 2021.
Bottom-line, the data shows that the cannabis industry has a positive economic impact on states and communities, and that impact hasn’t peaked yet.
Originally published 11/13/18. Updated 9/24/21.
PlatoAi. Web3 Reimagined. Data Intelligence Amplified.
Click here to access.
CBD (Cannabidiol) Explained – The Real Benefits of this Trendy Cannabinoid
While a fringe, alternative treatment option only a decade ago, today, CBD is everywhere you look – in wellness supplements, beauty and hygiene products, FDA-approved prescription medications, food and beverages, dental products, and even pillows, mattresses, and other random household goods.
As far as cannabinoids go, CBD, or cannabidiol) is the most widely accepted. Not only is there a growing body of clinical research to support its benefits, but it is non-intoxicating which makes it much more likely for laws to be passed in its favor – as is evidenced by the fact that CBD is federally legal in the US and many other countries, while THC still is not. But when it comes to CBD, what are some actual legitimate uses for this compound, and which ones are just marketing gimmicks? Let’s take a look at some of the real, science-backed benefits of CBD.
CBD is amazing, and so incredibly versatile. To learn more about this compound, and for exclusive deals on CBD flowers, as well as on Delta 8, Delta 10 THC, THCV, THC-O, THCP, HHC and even on legal Delta-9 THC! , make sure to subscribe to The CBD Flowers Weekly Newsletter, your hub for all things CBD-related.
What is CBD?
CBD, or cannabidiol, is the most prominent, non-intoxicating compound found in cannabis plants. When most people think of cannabis, they’re thinking about marijuana, which is the type so cannabis that is high in THC and associated with feelings of being “stoned”. Some types of cannabis, hemp for example, are high in CBD and contain only trace amounts of THC, meaning these plants can be considered non-intoxicating, by all accounts.
CBD is gaining popularity as a safe, non-toxic, non-addictive, natural treatment option for many different chronic and debilitating ailments; both mental and physical. Not only is CBD itself non-psychoactive, but when taken in combination with compounds that are, like tetrahydrocannabinol for instance, CBD can minimize the likelihood of negative side effects such as paranoia and anxiety that are occasionally associated with THC use.
The reason CBD (or any cannabinoid for that matter) works in the human body at all is because of the Endocannabinoid System (ECS) – a complex signaling system made up of numerous receptors, as well as some naturally produced endocannabinoids, that exists in the bodies of nearly all animals (except insects). Researchers have discovered two different endocannabinoids so far, 2-arachidonoylglycerol (2-AG) and anandamide (AEA), plus the two most studied receptors, CB1 and CB2. This quad makes up the majority of existing cannabis research.
As a whole, the ECS regulates numerous different functions and processes in our bodies and maintains internal balance and homeostasis. Many cannabinoids engage directly with the ECS receptors. Others, like CBD, have indirect connections by activating other receptors that will then interact with the endocannabinoid system. Specifically, CBD activates the TRVP1 receptors, which in turn activate receptors in the ECS and also function as ion channels.
CBD as an Anti-Inflammatory
One of the most common uses for CBD is to treat inflammation, which is the body’s process of fighting against pathogens and other hazards, such as infections, injuries, and toxins. When something damages your cells, your body releases chemicals that trigger a response from your immune system, thus causing inflammation.
The phrase “too much of a good thing” really applies in the case of inflammation. When this inflammatory response lingers after your body is done fighting the infection or whatever it is trying to overcome, this leaves your body in a constant state of stress and unrest. Chronic inflammation can have devastating effects on the tissues and organs and research indicates that it’s the root cause of many ailments including arthritis, contact dermatitis, acne, multiple sclerosis, and type 1 diabetes, asthma, and cancer.
Cannabidiol is becoming a very popular alternative for standard NSAID (Nonsteroidal anti-inflammatory drug) drugs like Aspirin. Long-term use of NSAIDs can lead to various health problems such as heartburn, stomach pain, ulcers, headaches, dizziness, and even damage to the liver and kidneys.
CBD to Manage Anxiety
Anxiety is another condition that’s been researched extensively to determine how well it responds to cannabis therapies. Cannabidiol targets cell receptors in the body and brain that regulate your mood. Many mood disorders, including anxiety and depression, have a few things in common, including a lack of naturally produced endocannabinoids.
Treating mood disorders with CBD is becoming more widespread is among the top-rated treatment options for young adults ages 25-40. According to a study conducted a couple of years ago, thirty-four percent of millennials prefer to manage their mental health with natural and holistic remedies, and 50 percent of millennials believe CBD oil is the best way to do this; and this number continues to grow.
The main reason cited was a fear of being prescribed a medication that is too potent for their level of symptoms. Because CBD doesn’t have the mind-numbing and other unwanted side effects of prescription drugs, nor is it psychoactive like THC, it can be used all day like any other medication or supplement.
CBD for Controlling Seizures
One of the first, medically-accepted, modern-day uses for CBD was to treat epilepsy. There are many studies out there researching its effectiveness. As a matter of fact, there is even an FDA-approved, cannabidiol-based medication, Epidiolex, that’s used to treat two rare and severe forms of childhood epilepsy, Lennox-Gastaut Syndrome (LGS) and Dravet Syndrome (DS).
Epidiolex is currently being prescribed in the United States, many countries in Europe, and Japan. Epilepsy medications can have some very serious side effects, and that’s why more natural alternatives are becoming the go-to way to treat children and younger adult patients who suffer from epilepsy.
CBD for Pain Management
Although not common, many patients turn to a CAM, or complementary alternative medicine approach, to manage chronic pain. CBD is at the top of the list for those looking for natural, yet effective, alternative remedies. Because inflammation is the root cause of so many conditions that cause chronic pain, it makes sense how CBD eliminates pain.
Numerous different studies have found that cannabinoids like CBD can help with chronic pain from multiple sclerosis, cancer, and neuropathy. CBD and CBD topicals help with pain — if you suffer from chronic pain, CBD oil may help, as well. Chronic pain can be the main source of a diminished quality of life — CBD may give you hope for getting pain-free, or at the very least, reduced pain, and anything is worth a try.
CBD for Skin Conditions
Studies have shown that CBD can provide relief for the symptoms of various skin disorders, such as eczema and allergic reactions. Reverting back to inflammation, we know that cannabidiol can be used internally inflammatory conditions, and now we also know that it does the same when applied topically.
Topical creams containing CBD have been shown to or greatly reduce and sometimes even completely eliminate itching and dryness in sufferers of eczema. The chemical ‘histamine’, which is largely responsible for the irritating itches we experience, has been shown to react well to topical cannabinoid therapy. One study found that in almost 59% of its participants, their dry and scaly skin significantly reduced with the regular use of a cannabinoid cream, which reduced itching and as a result lead to less sleep loss.
Final Thoughts on Cannabidiol Benefits
Simply put, cannabidiol is an incredible compound. It’s non-psychoactive, non-toxic, and non-addictive; and it can be used to treat dozens of different health conditions. The ones covered in this list are the most common uses for CBD, but it can be utilized for many other ailments as well. Do you use CBD? And if so, what do you use it for? Drop us a line in the comment section below!
Thank you for stopping by CBD TESTERS, your hub for all things cannabis-related. To learn more about weed, and for exclusive deals on flowers, vapes, edibles, topicals, and other products, make sure to subscribe to The CBD Flowers Weekly Newsletter.
PlatoAi. Web3 Reimagined. Data Intelligence Amplified.
Click here to access.
Microsoft’s The Initiative brings on Crystal Dynamics to help develop its Perfect Dark reboot
Twitch celebrity meetup Sh*tCamp 2021 begins today
NBA 2K22 ‘Meet the Designers’ Quest Guide: How to Complete
FIFA 22 Early Access Pack: How to Get
How to play Worlds 2021 Pick’em
Valorant Patch 3.07 Release Date: When is it?
New World Interactive Map Tools Help Players Explore Aeternum While Offline
Tools of the Trade Diablo II: Resurrected Quest Guide
Mikaela Reid Added as Newest Survivor in DBD PTB
Best MTG Arena Standard Metagame Innistrad 2021-2022 decks
[D-ID in Tech Crunch] D-ID launches ‘Speaking Portrait,’ a way to turn photos into custom, photo-realistic videos
Horadric Cube Diablo II: Resurrected Guide
NBA 2K22 Current Gen Elevator Bug: How to Fix
How to charge an iPhone 13?
The best weapon combinations in New World
Overwatch League reveals 2021 Role Stars
Is Death Stranding Director’s Cut Coming to PC?
Cardano Smart Contracts Could Be Under Serious Threat, Bitcoin Is Here!
‘Iron Men’ to Rise in AI-Augmented Business Landscape
The FBI’s Decision to Withhold the Decryption Keys for the Kaseya Ransomware has Sparked Discussion
Esports6 days ago
How to start a Private Queue in CS:GO
Esports5 days ago
Can You Play Diablo II: Resurrected Offline?
Esports7 days ago
Here are all of CS:GO’s Operation Riptide skins
Esports6 days ago
How to complete all week one missions in Operation Riptide
Esports1 week ago
Clash Royale League World Finals 2021 will take place in December with a $1,020,000 prize pool
Esports6 days ago
Where is TwitchCon 2022 being held?
Esports1 week ago
5 Best Counters to Vex in League of Legends
Esports7 days ago
Valve reveals CS:GO Operation Riptide, featuring private queue, short competitive games, new deathmatch modes, and more
Fintech6 days ago
JP Morgan Taps Thought Machine to Replace Retail Banking Core
Esports6 days ago
Valkyrae says YouTube is working on gifted members and a feature similar to Twitch Prime
Covid196 days ago
Florida Makes Quarantine Optional For Students Exposed To COVID-19
Esports5 days ago
Microsoft’s The Initiative brings on Crystal Dynamics to help develop its Perfect Dark reboot